Brussels, 30/10/2013 (Agence Europe) - Experts from the pharmaceutical sector, members of the Committee for Medicinal Products for Human Use of the European Medicines Agency (CHMP) and of the Pharmacovigilance Risk Assessment Committee (PRAC) met in Vilnius on 29 and 30 October. The aim was to discuss the preparation of European strategic benchmarks for the development of European medicines and the criteria for the selection of experts for European arbitration procedures and their...